Evofem Biosciences Raises $50M In Offering
socalTECH
MAY 21, 2021
San Diego-based Evofem Biosciences, a developer of biopharmaceuticals for female reproductive health, reported it raised $50M in its previously announced public offering. It said it will net approximately $46.6M after underwriting discounts, commissions, and expenses.
Let's personalize your content